Release
📈 Stocks
Mabwell to Present Phase II Data for Nectin-4 ADC 9MW2821 in Breast Cancer
(9 minutes ago)
Mabwell prepares to showcase Phase II clinical data for its 9MW2821 ADC, marking a critical development step for its oncology portfolio in…